COVID-19 vaccination | p -value | ||
---|---|---|---|
No (n = 422) | Yes (n = 109) | ||
Sex, male (%) | 60.9 | 53.2 | 0.15 |
Age (years)a | 60.9 ± 1.0 | 71.3 ± 1.9 | 0.01 |
BMI (kg/m2)a | 23.7 ± 0.2 | 22.1 ± 0.5 | 0.01 |
CRP (mg/dl)a | 8.11 ± 0.38 | 5.56 ± 0.65 | 0.01 |
Past history (%) | |||
Diabetes mellitus | 27.3 | 21.1 | 0.19 |
Hypertension | 36.3 | 44.0 | 0.14 |
Dyslipidemia | 23.0 | 22.9 | 0.99 |
Chronic kidney disease | 13.3 | 15.6 | 0.53 |
Heart failure | 3.3 | 10.1 | < 0.01 |
Malignancy | 5.2 | 11.0 | 0.03 |
Cerebral disease b | 6.6 | 9.2 | 0.36 |
Dementia | 8.5 | 10.1 | 0.61 |
Psychiatric diseases c | 4.3 | 3.7 | 1.00 |
Severity of COVID-19 | < 0.01 | ||
Mild (%) | 48.6 | 62.4 | |
Moderate (%) | 40.5 | 35.8 | |
Severe (%) | 10.9 | 1.8 | |
COVID-19 interventions (%) | |||
Remdesivir | 41.0 | 45.0 | 0.46 |
Steroid | 52.4 | 31.2 | < 0.01 |
Mechanical ventilation | 12.6 | 1.8 | < 0.01 |